IDPM: PMC3784205
Return the vial to the refrigerator promptly, protected from light
The ClinicalTrials.gov registry shows multiple ongoing tirzepatide studies, but all focus on metabolic endpoints (weight loss, diabetes management, cardiovascular outcomes, obstructive sleep apnea) rather than autoimmune disease activity
Vero cells treated similarly with different concentrations of PZQ, MZM and AF (Cayman Chemicals) were used as positive controls
Dihexa is reported to be active at picomolar concentrations in synaptogenesis assaysapproximately 10,00010,000,000-fold more potent than BDNF (brain-derived neurotrophic factor) in some in vitro measures, though this comparison involves different assay conditions and should not be taken as a direct clinical equivalence claim
This makes it appealing in studies exploring muscle-wasting conditions or injury recovery